Research

Zacks Small Cap Research – RERE: 4Q24 Earnings Review: EPS as Expected; Investing for Growth to Keep Pace with Accelerating Demand – Go Health Pro

by

By Michael Kim NYSE:RERE READ THE FULL RERE RESEARCH REPORT Pre-market open on 3/11/25, ATRenew (NYSE:RERE) reported 4Q24 earnings results. On a GAAP basis, RERE reported net income of $10.6 million for 4Q24, or $0.04 per ADS. That said, excluding non-cash share-based compensation and intangible assets amortization expenses, adjusted EPS came in at $0.07, or … Read more

Zacks Small Cap Research – REVB Starts 2025 With Bright Future Ahead – Go Health Pro

by

By Brad Sorensen, CFA NASDAQ:REVB READ THE FULL REVB RESEARCH REPORT Revelation Biosciences (NASDAQ:REVB) is a life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. Revelation has multiple product candidates in development that we believe have promising potential and are based on the biology of phosphorylated hexaacyl … Read more

Qube Research & Technologies (QRT) hires Securis cat bond specialist Rayees – Go Health Pro

by
Qube Research & Technologies (QRT) hires Securis cat bond specialist Rayees – Go Health Pro

Qube Research & Technologies (QRT), a global quantitative and systematic investment manager that specialises in a technology and data-driven approach to allocation across liquid asset classes, has hired Securis catastrophe bond portfolio management specialist Raphael Rayees, the company has confirmed.Qube Research & Technologies (QRT) entered the insurance-linked securities (ILS) market recently, launching a quantitative trading … Read more

New research shows bigger animals get more cancer, defying decades-old belief – Go Health Pro

by
New research shows bigger animals get more cancer, defying decades-old belief – Go Health Pro

The answer lies in how quickly body size evolves. We found that birds and mammals that reached large sizes more rapidly have reduced cancer prevalence. For example, the common dolphin, Delphinus delphis evolved to reach its large body size—along with most other whales and dolphins (referred to as cetaceans) about three times faster than other … Read more

Zacks Small Cap Research – CVKD: Collaborating with Abbott for Pivotal Phase 3 Trial… – Go Health Pro

by

By David Bautz, PhD NASDAQ:CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Collaboration Agreement with Abbott for Phase 3 TECH-LVAD Trial On March 4, 2025, Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) announced a collaboration agreement with Abbott for the Phase 3 TECarfarin Anticoagulation and Hemocompatibility with Left Ventricular Assist Devices (TECH-LVAD) trial. In August 2024, Cadrenal … Read more

x